151 related articles for article (PubMed ID: 35382904)
1. Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity.
Venkatesh R; Reddy NG; Mishra P; Agrawal S; Mutalik D; Yadav NK; Chhablani J
Int J Retina Vitreous; 2022 Apr; 8(1):26. PubMed ID: 35382904
[TBL] [Abstract][Full Text] [Related]
2. Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia.
Reddy NG; Prabhu V; Sharma SV; Acharya I; Mangla R; Yadav NK; Chhablani J; Narayanan R; Venkatesh R
Int J Retina Vitreous; 2023 Aug; 9(1):47. PubMed ID: 37559099
[TBL] [Abstract][Full Text] [Related]
3. The preproliferative stage in type 2 macular telangiectasia (MacTel type 2).
Venkatesh R; Reddy NG; Mishra P; Pereira A; Mutalik D; Agrawal S; Bhatt A; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2022 Jan; 260(1):121-132. PubMed ID: 34410484
[TBL] [Abstract][Full Text] [Related]
4. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
5. Characteristics of retinal pigment clumps in Type 2 macular telangiectasia (MacTel).
Venkatesh R; Agrawal S; Reddy NG; Mishra P; Mutalik D; Yadav NK; Chhablani J
Eye (Lond); 2023 Apr; 37(6):1061-1066. PubMed ID: 35422496
[TBL] [Abstract][Full Text] [Related]
6. EARLY SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY BIOMARKERS TO CONFIRM FELLOW EYE CHANGES IN ASYMMETRIC TYPE-2 MACULAR TELANGIECTASIA: A Case-Control Study (India Macular Telangiectasia Report 1).
Alex D; Giridhar A; Gopalakrishnan M; Manayath G; Amar S; Raman R; Sreenivasan R; Ayachit A; Sivaprasad S
Retina; 2021 Mar; 41(3):471-479. PubMed ID: 32804830
[TBL] [Abstract][Full Text] [Related]
7. Optical coherence tomographic features of macular telangiectasia type 2: Korean Macular Telangiectasia Type 2 Study-Report No. 1.
Kim YH; Chung YR; Oh J; Kim SW; Lee CS; Yun C; Lee B; Ahn SM; Choi EY; Jang S; Lee K
Sci Rep; 2020 Oct; 10(1):16594. PubMed ID: 33024250
[TBL] [Abstract][Full Text] [Related]
8. Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity.
Srinivasan R; Teussink MM; Sloan KR; Bharat RPK; Narayanan R; Raman R
BMC Ophthalmol; 2022 Jun; 22(1):264. PubMed ID: 35698056
[TBL] [Abstract][Full Text] [Related]
9. Outer retinal hyperreflective spots on spectral-domain optical coherence tomography in macular telangiectasia type 2.
Baumüller S; Charbel Issa P; Scholl HP; Schmitz-Valckenberg S; Holz FG
Ophthalmology; 2010 Nov; 117(11):2162-8. PubMed ID: 20557944
[TBL] [Abstract][Full Text] [Related]
10. Tamoxifen Retinopathy and Macular Telangiectasia Type 2: Similarities and Differences on Multimodal Retinal Imaging.
Hess K; Park YJ; Kim HA; Holz FG; Charbel Issa P; Yoon YH; Tzaridis S
Ophthalmol Retina; 2023 Feb; 7(2):101-110. PubMed ID: 35948211
[TBL] [Abstract][Full Text] [Related]
11. Vitreomacular interface abnormalities in type 2 macular telangiectasia (MacTel).
Venkatesh R; Mangla R; Handa A; Chitturi SP; Parmar Y; Sangoram R; Yadav NK; Chhablani J
Graefes Arch Clin Exp Ophthalmol; 2024 May; 262(5):1455-1463. PubMed ID: 38108907
[TBL] [Abstract][Full Text] [Related]
12. Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2.
Chandran K; Desai S; Giridhar A
Oman J Ophthalmol; 2023; 16(2):377-381. PubMed ID: 37602186
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen retinopathy and macular telangiectasia: A comparative case series.
Venkatesh R; Sharief S; Jayadev C; Reddy NG; Mangla R; Agrawal R; Yadav NK; Chhablani J
Eur J Ophthalmol; 2022 Nov; ():11206721221142637. PubMed ID: 36437624
[TBL] [Abstract][Full Text] [Related]
14. CHARACTERIZING RETINAL-CHOROIDAL ANASTOMOSIS IN MACULAR TELANGIECTASIA TYPE 2 WITH OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
Breazzano MP; Yannuzzi LA; Spaide RF
Retina; 2020 Jan; 40(1):92-98. PubMed ID: 31246676
[TBL] [Abstract][Full Text] [Related]
15. Progression of vascular changes in macular telangiectasia type 2: comparison between SD-OCT and OCT angiography.
Pauleikhoff D; Gunnemann F; Book M; Rothaus K
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1381-1392. PubMed ID: 31093765
[TBL] [Abstract][Full Text] [Related]
16. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
[TBL] [Abstract][Full Text] [Related]
17. Epiretinal Neovascularization: A Novel OCT Angiography Finding in Macular Telangiectasia Type 2.
Ayachit AG; Reddy LU; Joshi S; Ayachit GS
Ophthalmol Retina; 2019 Jun; 3(6):516-522. PubMed ID: 31174674
[TBL] [Abstract][Full Text] [Related]
18. Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2.
Abdul-Rahman A
BMC Ophthalmol; 2020 Jun; 20(1):213. PubMed ID: 32493257
[TBL] [Abstract][Full Text] [Related]
19. AN UPDATED STAGING SYSTEM OF TYPE 3 NEOVASCULARIZATION USING SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY.
Su D; Lin S; Phasukkijwatana N; Chen X; Tan A; Freund KB; Sarraf D
Retina; 2016 Dec; 36 Suppl 1():S40-S49. PubMed ID: 28005662
[TBL] [Abstract][Full Text] [Related]
20. SPECTRAL DOMAIN OPTICAL COHERENCE TOMOGRAPHY FEATURES IN DIFFERENT STAGES OF BEST VITELLIFORM MACULAR DYSTROPHY.
Battaglia Parodi M; Iacono P; Romano F; Bandello F
Retina; 2018 May; 38(5):1041-1046. PubMed ID: 28376040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
